v3 Template
A

Avacta Therapeutics

Biotechnology / Therapeutics London and Philadelphia ~440 employees
Founded
--
Employees (Est.)
~440
22 leaders known
Total Funding
$4.2M
Funding Rounds
1
Last Funding
2025-08-29

About Avacta Therapeutics

Avacta Therapeutics is focused on expanding the reach of highly potent cancer therapies through their proprietary pre|CISION(r) platform, emphasizing hope without compromise in cancer treatment.

Products & Services

pre|CISION(r) Peptide Drug Conjugate Platform:A platform for developing targeted cancer therapies.

Specialties

Targeted Cancer Therapies Peptide Drug Conjugates Clinical Trials

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Fundraise with Convertible Bond
T: -
FT: Fundraise with Convertible Bond 		A: 4225000
MR: -
FA: £3.25 Million
FAN: 4225000 		D: 2025-08-29
FD: 2025-08-29 		-
Fundraise with Convertible Bond Latest
2025-08-29
$4.2M

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

C

Christina Coughlin

Chief Executive Officer

K

Karen Harrison

Chief Operating Officer

LinkedIn (Pro only)
S

Simon Bennett

Chief Business Officer

M

Michelle Morrow

Chief Scientific Officer

B

Brian Hahn

Chief Financial Officer

D

David Liebowitz

Chief Medical Officer

View 19 more team members with Pro

Unlock Full Team Directory

Recent News

Avacta Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
avacta.com
Industries
Biotechnology / Therapeutics
Company Size
~440 employees (est.)
Locations
London and Philadelphia

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro